Ionis Pharmaceuticals Inc (IONS) — Cash Flow-to-Debt Ratio
Ionis Pharmaceuticals Inc (IONS) has a Cash Flow-to-Debt Ratio of -0.05x as of September 2025, meaning its operating cash flow of $-131.44 Million could theoretically repay 0% of its total liabilities ($2.42 Billion) in one year. Explore Ionis Pharmaceuticals Inc (IONS) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ionis Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1991–2024)
Historical debt coverage capacity for Ionis Pharmaceuticals Inc across 34 annual periods. Also explore Ionis Pharmaceuticals Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Ionis Pharmaceuticals Inc (1991–2024)
Year-by-year debt coverage analysis for Ionis Pharmaceuticals Inc. For market capitalisation and broader financial context, see IONS company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.21x | $-500.95 Million | $2.42 Billion | ▼ -75.6% |
| 2023 | -0.12x | $-307.51 Million | $2.60 Billion | ▲ +15.6% |
| 2022 | -0.14x | $-274.37 Million | $1.96 Billion | ▼ -935.9% |
| 2021 | 0.02x | $30.80 Million | $1.84 Billion | ▼ -27.9% |
| 2020 | 0.02x | $35.89 Million | $1.55 Billion | ▼ -89.6% |
| 2019 | 0.22x | $345.72 Million | $1.55 Billion | ▼ -45.2% |
| 2018 | 0.41x | $602.89 Million | $1.48 Billion | ▲ +111.2% |
| 2017 | 0.19x | $174.15 Million | $903.30 Million | ▲ +239.8% |
| 2016 | -0.14x | $-112.11 Million | $812.90 Million | ▼ -593.1% |
| 2015 | 0.03x | $21.12 Million | $755.32 Million | ▲ +210.6% |
| 2014 | 0.01x | $6.29 Million | $698.03 Million | ▼ -93.4% |
| 2013 | 0.14x | $63.49 Million | $468.77 Million | ▲ +2520.3% |
| 2012 | 0.01x | $1.88 Million | $362.92 Million | ▲ +101.4% |
| 2011 | -0.37x | $-114.80 Million | $313.46 Million | ▼ -76.2% |
| 2010 | -0.21x | $-63.59 Million | $305.94 Million | ▲ +31.9% |
| 2009 | -0.31x | $-108.44 Million | $355.12 Million | ▼ -167.7% |
| 2008 | 0.45x | $212.03 Million | $469.90 Million | ▲ +210.8% |
| 2007 | 0.15x | $36.09 Million | $248.62 Million | ▲ +143.1% |
| 2006 | -0.34x | $-53.23 Million | $158.00 Million | ▲ +10.7% |
| 2005 | -0.38x | $-61.74 Million | $163.71 Million | ▼ -4.0% |
| 2004 | -0.36x | $-101.75 Million | $280.56 Million | ▼ -1.7% |
| 2003 | -0.36x | $-95.47 Million | $267.76 Million | ▼ -7.0% |
| 2002 | -0.33x | $-94.38 Million | $283.21 Million | ▼ -949.7% |
| 2001 | -0.03x | $-6.16 Million | $193.96 Million | ▲ +84.0% |
| 2000 | -0.20x | $-23.19 Million | $116.89 Million | ▲ +58.1% |
| 1999 | -0.47x | $-48.40 Million | $102.31 Million | ▼ -36.7% |
| 1998 | -0.35x | $-34.70 Million | $100.30 Million | ▼ -39.4% |
| 1997 | -0.25x | $-20.60 Million | $83.00 Million | ▲ +49.8% |
| 1996 | -0.49x | $-21.20 Million | $42.90 Million | ▲ +22.4% |
| 1995 | -0.64x | $-15.10 Million | $23.70 Million | ▲ +13.7% |
| 1994 | -0.74x | $-15.20 Million | $20.60 Million | ▲ +2.1% |
| 1993 | -0.75x | $-15.30 Million | $20.30 Million | ▲ +39.0% |
| 1992 | -1.24x | $-19.40 Million | $15.70 Million | ▼ -1094.5% |
| 1991 | -0.10x | $-1.50 Million | $14.50 Million | — |